A study to determine the correlation of insulin resistance in pregnancy with obstetric outcomes
DOI:
https://doi.org/10.18203/2320-1770.ijrcog20252316Keywords:
Insulin resistance, Pregnancy, Obstetric outcome, Maternal complications, Neonatal outcomeAbstract
Background: Insulin resistance (IR) is a physiological adaptation in pregnancy but can predispose to adverse maternal and fetal outcomes if dysregulated. Early identification and monitoring are essential to improve obstetric outcomes and reduce the risk of gestational diabetes mellitus (GDM).
Methods: This prospective observational study was conducted at MTH Hospital, Indore, over one year. A total of 200 pregnant women with gestational age up to 26 weeks attending the antenatal clinic were screened for clinical signs of insulin resistance. Those with fasting plasma glucose ≥140 mg/dl or diagnosed with GDM were excluded. Remaining participants were followed up till delivery for obstetric outcomes. Data were collected using a predesigned proforma and analyzed with standard statistical tools.
Results: Among the 200 participants, a significant proportion with clinical features of insulin resistance were found to have increased rates of obstetric complications such as preeclampsia, polyhydramnios, preterm labor, and neonatal hypoglycemia. A positive correlation was observed between maternal BMI and adverse perinatal outcomes. Insulin-resistant women had higher rates of labor induction and cesarean deliveries compared to their non-resistant counterparts.
Conclusion: Early screening for insulin resistance in pregnancy is crucial in peripheral setups. Timely diagnosis and appropriate management can significantly improve maternal and neonatal outcomes.
Metrics
References
Mulla W, Patel M, Shah A. Association of maternal obesity and insulin resistance with adverse pregnancy outcomes. J Obstet Gynaecol India. 2020;70(1):45–50.
Kaushal SK, Bihari V, Shukla AK. Obesity and insulin resistance in early pregnancy and their effect on pregnancy outcome. Indian J Endocrinol Metab. 2018;22(5):625–30.
Jayasena CN. Clinical markers of insulin resistance in women: A simple guide for gynecological practice. Int J Gynaecol Obstet. 2019;146(3):253–9.
Bartha JL, Martinez-Del-Fresno P, Comino-Delgado R. Insulin resistance and its relationship with adverse pregnancy outcomes in gestational diabetes. Eur J Obstet Gynecol Reprod Biol. 2005;119(2):182–6.
Catalano PM, Ehrenberg HM. The short- and long-term implications of maternal obesity on the mother and her offspring. BJOG. 2006;113(10):1126–33. DOI: https://doi.org/10.1111/j.1471-0528.2006.00989.x
American College of Obstetricians and Gynecologists. Gestational Diabetes Mellitus. Practice Bulletin No. 190. Obstet Gynecol. 2018;131(2):49–64. DOI: https://doi.org/10.1097/AOG.0000000000002501
Buchanan TA, Xiang AH. Gestational diabetes mellitus. J Clin Invest. 2005;115(3):485–91. DOI: https://doi.org/10.1172/JCI200524531
Nanda S, Savvidou M, Syngelaki A, Akolekar R, Nicolaides KH. Prediction of gestational diabetes mellitus by maternal factors and biomarkers at 11 to 13 weeks. Prenat Diagn. 2011;31(2):135–41. DOI: https://doi.org/10.1002/pd.2636
Metzger BE, Gabbe SG, Persson B, et al. International association of diabetes and pregnancy study groups recommendations on the diagnosis and classification of hyperglycemia in pregnancy. Diabetes Care. 2010;33(3):676–82. DOI: https://doi.org/10.2337/dc09-1848
Simmons D. Diabetes and obesity in pregnancy: A global challenge. Best Pract Res Clin Obstet Gynaecol. 2015;29(3):289–99.